This Drug Company Just Got Caught Jacking Up the Price of a Baby Medicine by 85,000%

This week, drug manufacturer Mallinckrodt Pharmaceuticals settled a lawsuit with the US Federal Trade Commission (FTC) for US$100 million, for engaging in illegal anti-competitive behaviour to ensure its continued monopoly over a life-saving medication for infants with epilepsy. More than a decade ago, Acthar Gel sold for $40 a vial, but since it's been acquired by Mallinckrodt, the price has been raised to more than $34,000 a vial, netting the company more than $1 billion in revenue in 2015.
Read more: http://www.sciencealert.com/this-drug-company-just-admitted-to-jacking-up-the-price-of-a-baby-medicine-by-85-000?source=Snapzu